me-rip m6a transcriptome profiling kit (Ribobio co)
Structured Review
Me Rip M6a Transcriptome Profiling Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+profiles/me+rip+m6a+transcriptome+profiling+kit/pm36319624-114-5-10
Average 90 stars, based on 1 article reviews
Images
Related Articles
Modification:Article Title: Methyltransferase-like 7B participates in bladder cancer via ACSL3 m 6 A modification in a ferroptosis manner Article Snippet: .. m 6 A modification on ACSL3 was validated by MeRIP-RT-qPCR assay referred to [ ] using Article Title: Methyltransferase-like 7B participates in bladder cancer via ACSL3 m 6 A modification in a ferroptosis manner. Article Snippet: .. m6A modification on ACSL3 was validated by MeRIPRT-qPCR assay referred to [20] using other:Article Title: Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1. Article Snippet: Me-RIP was performed using the Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. Article Title: METTL3 knockdown suppresses RA-FLS activation through m 6 A-YTHDC2-mediated regulation of AMIGO2. Article Snippet: The dysregulation of N6-methyladenosine (m6A) on mRNAs is involved in the pathogenesis of rheumatoid arthritis (RA).. Methyltransferase-like 3 (METTL3), serving as a central m6A methyltransferase, is highly expressed in macrophages, synovial tissues and RA fibroblast-like synoviocytes (RA-FLS) of RA patients.. However, METTL3-mediated m6A modification on target mRNAs and the molecular mechanisms involved in RA-FLS remain poorly defined. Article Title: FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. Article Snippet: Funding information Ningbo Municipal Natural Science Foundation Project, Grant/Award Number: 2022J036 Abstract Early treatment of retinoblastoma (RB) has significantly improved clinical outcomes.. N6‐ methyladenosine (m6A) methylation is crucial for cancer progression.. Thus, we investigated the role of FTO‐dependent demethylation in RB and its underlying mechanisms. |
